^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ACT-903

    i
    Company:
    Alpha Cancer Technologies
    Drug class:
    Tubulin inhibitor, AFP-targeted antibody-drug conjugate
    Related drugs: